The prothrombotic state in Hypertension and the effects of antihypertensive treatmentNADAR, Sunil; LIP, Gregory Y. H.Current pharmaceutical design. 2003, Vol 9, Num 21, pp 1715-1732, issn 1381-6128, 18 p.Article

Implications of the CHA₂DS₂-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial FibrillationLIP, Gregory Y. H.The American journal of medicine. 2011, Vol 124, Num 2, pp 111-114, issn 0002-9343, 4 p.Article

Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary interventionLIP, Gregory Y. H.BMJ. British medical journal (International ed.). 2008, Vol 337, Num 7678, pp 1110-1112, issn 0959-8146, 3 p.Article

Antihypertensive DrugsLIP, Gregory Y. H.Current pharmaceutical design. 2003, Vol 9, Num 21, issn 1381-6128, 91 p.Serial Issue

Target organ damage and the prothrombotic state in hypertensionLIP, Gregory Y. H.Hypertension (Dallas, Tex. 1979). 2000, Vol 36, Num 6, pp 975-977, issn 0194-911XArticle

Hypertension to heart failure: New developmental strategies do not cross a clinical and therapeutic divideMACFADYEN, Robert J; LIP, Gregory Y. H; DAVIS, Russell et al.Current pharmaceutical design. 2003, Vol 9, Num 21, pp 1665-1678, issn 1381-6128, 14 p.Article

What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?AHRENS, Ingo; LIP, Gregory Y. H; PETER, Karlheinz et al.Thrombosis and haemostasis. 2011, Vol 105, Num 4, pp 574-578, issn 0340-6245, 5 p.Article

A New Landscape for Stroke Prevention in Atrial Fibrillation: Focus on New Anticoagulants, Antiarrhythmic Drugs, and DevicesBANERJEE, Amitava; MARIN, Francisco; LIP, Gregory Y. H et al.Stroke (1970). 2011, Vol 42, Num 11, pp 3316-3322, issn 0039-2499, 7 p.Article

Atrial fibrillation and mortality: the impact of antithrombotic therapyLANE, Deirdre A; LIP, Gregory Y. H.European heart journal. 2010, Vol 31, Num 17, pp 2075-2076, issn 0195-668X, 2 p.Article

New oral anticoagulant drugs in cardiovascular diseaseAHRENS, Ingo; LIP, Gregory Y. H; PETER, Karlheinz et al.Thrombosis and haemostasis. 2010, Vol 104, Num 1, pp 49-60, issn 0340-6245, 12 p.Article

Acute Management of Atrial FibrillationKHOO, Chee W; LIP, Gregory Y. H.Chest (American College of Chest Physicians). 2009, Vol 135, Num 3, pp 849-859, issn 0012-3692, 11 p.Article

Variability of response to antiplatelet therapy : what should we do next?SHANTSILA, Eduard; LIP, Gregory Y. H.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 19-22, issn 0767-3981, 4 p.Article

Platelet adhesion in congestive heart failureCHUNG, Irene; CHOUDHURY, Anirban; LIP, Gregory Y. H et al.Thrombosis research. 2008, Vol 121, Num 6, pp 885-888, issn 0049-3848, 4 p.Article

From diabetes to metabolic syndrome : A view point on an evolving concept : The clinical management and treatment of hypertension, its pathophysiology and the clinical use of antihypertensive drugsHOONG SERN LIM; LIP, Gregory Y. H.Current pharmaceutical design. 2007, Vol 13, Num 25, pp 2580-2583, issn 1381-6128, 4 p.Article

Modern management of atrial fibrillationWATSON, Timothy; SHANSTILA, Eduard; LIP, Gregory Y. H et al.Clinical medicine. 2007, Vol 7, Num 1, pp 28-34, issn 1470-2118, 7 p.Article

Fondaparinux : Cardiovascular and hematological agentsTAN, Kiat T; LIP, Gregory Y. H.Current pharmaceutical design. 2005, Vol 11, Num 4, pp 415-419, issn 1381-6128, 5 p.Article

Pharmacological treatment of hypertension in pregnancyAFIFI, Y; CHURCHILL, D.Current pharmaceutical design. 2003, Vol 9, Num 21, pp 1745-1753, issn 1381-6128, 9 p.Article

Endothelin binding and calcium signalling in hypertensionTAYEBJEE, Muzahir; LIP, Gregory Y. H. H.Journal of hypertension. 2002, Vol 20, Num 9, pp 1711-1712, issn 0263-6352Article

Blood pressure measurement. Part II-Conventional sphygmomanometry : technique of auscultatory blood pressure measurementBEEVERS, Gareth; LIP, Gregory Y. H; O'BRIEN, Eoin et al.BMJ. British medical journal (International ed.). 2001, Vol 322, Num 7293, pp 1043-1047, issn 0959-8146Article

Blood pressure measurement: Part III-Automated sphygmomanometry : ambulatory blood pressure measurementO'BRIEN, Eoin; BEEVERS, Gareth; LIP, Gregory Y. H et al.BMJ. British medical journal (International ed.). 2001, Vol 322, Num 7294, pp 1110-1114, issn 0959-8146Article

Hormone Replacement Therapy and hypertensionFELMEDEN, Dirk C; LIP, Gregory Y. H.Blood pressure. 2000, Vol 9, Num 5, pp 246-249, issn 0803-7051Article

Which is the Optimal Antihypertensive Combination in Different Diseases, a Renin-Angiotensin-aldosterone System Inhibitor with a Diuretic or with a Calcium Channel Blocker? : Achieving Curent Goals in Prevention and Treatment of Vascular Disease: An UpdateRIVA, Nicoletta; LIP, Gregory Y. H.Current pharmaceutical design (Print). 2013, Vol 19, Num 21, pp 3753-3765, issn 1381-6128, 13 p.Article

Use of the CHA₂DS₂-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial FibrillationLANE, Deirdre A; LIP, Gregory Y. H.Circulation (New York, N.Y.). 2012, Vol 126, Num 7, pp 860-865, issn 0009-7322, 6 p.Article

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort studyFRIBERG, Leif; ROSENQVIST, Mårten; LIP, Gregory Y. H et al.European heart journal. 2012, Vol 33, Num 12, pp 1500-1510, issn 0195-668X, 11 p.Article

Monocytes in Acute Coronary SyndromesSHANTSILA, Eduard; LIP, Gregory Y. H.Arteriosclerosis, thrombosis, and vascular biology. 2009, Vol 29, Num 10, pp 1433-1438, issn 1079-5642, 6 p.Article